Get the Stockscreener App
71.60
0.03%
-0.01
Henry Schein Inc stock is traded at $71.60, with a volume of 265.74K.
It is down -0.03% in the last 24 hours and up +6.80% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$71.61
Open:
$71.49
24h Volume:
265.74K
Relative Volume:
0.16
Market Cap:
$8.68B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
29.34
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
+14.88%
1M Performance:
+6.80%
6M Performance:
+7.53%
1Y Performance:
+3.77%
1-Day Range:
$70.89
$72.89
1-Week Range:
$62.32
$73.53
52-Week Range:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
71.58 | 8.49B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
837.88 | 104.69B | 377.60B | 3.35B | 5.67B | 25.06 |
|
COR
Cencora Inc
|
342.77 | 66.80B | 316.65B | 1.91B | 1.14B | 9.7209 |
|
CAH
Cardinal Health Inc
|
194.31 | 46.41B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
AHG
Akso Health Group Adr
|
1.70 | 873.83M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-26-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-25-25 | Downgrade | Stifel | Buy → Hold |
| Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Henry Schein One partners with Amazon Web Services to power its AI-driven dental ecosystem - Oral Health Group
Henry Schein, Inc. (NASDAQ:HSIC) Q3 2025 Earnings Call Transcript - Insider Monkey
VideaHealth and Henry Schein One Launch the Impact Panel, Bringing AI-Driven Patient Education to Dentrix and Dentrix Ascend - Stock Titan
Henry Schein Rings the Opening Bell - Nasdaq
Baird Adjusts Price Target on Henry Schein to $78 From $72, Maintains Neutral Rating - MarketScreener
Henry Schein (NASDAQ:HSIC) Issues FY 2025 Earnings Guidance - MarketBeat
Applying sector rotation models to Henry Schein Inc.2025 Market Trends & Fast Entry High Yield Stock Tips - newser.com
Henry Schein: Q3 Earnings Snapshot - CT Insider
Henry Schein Inc. stock volume spike explained2025 Price Momentum & Weekly High Return Stock Forecasts - newser.com
Henry Schein One, AWS Partner to Launch AI-Augmented Dental Practice System - Digital Health News
Will Henry Schein Inc. stock split again soonJuly 2025 Levels & Real-Time Buy Signal Alerts - newser.com
Henry Schein Reports Record Third Quarter 2025 Financial Results and Raises Full Year Non-GAAP EPS Guidance - BioSpace
Tools to assess Henry Schein Inc.’s risk profileGlobal Markets & AI Enhanced Trading Alerts - newser.com
What risks investors should watch in Henry Schein Inc. stockJuly 2025 Movers & AI Optimized Trade Strategies - newser.com
Has Henry Schein Inc. found a price floorShort Setup & Daily Volume Surge Trade Alerts - newser.com
Will Henry Schein Inc. rebound enough to break evenJuly 2025 Final Week & Real-Time Volume Spike Alerts - newser.com
Can Henry Schein Inc. stock hit analyst price targetsPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com
How hedge fund analytics apply to Henry Schein Inc. stockEarnings Trend Report & Growth Focused Stock Pick Reports - newser.com
Decoding Henry Schein Inc (HSIC): A Strategic SWOT Insight - GuruFocus
Henry Schein Reports Strong Q3 2025 Earnings - TipRanks
Henry Schein (HSIC) Margin Improvement Challenges Bearish Profitability Narrative After Five-Year Earnings Decline - Yahoo Finance
Henry Schein’s Earnings Call Highlights Growth and Challenges - TipRanks
Henry Schein Inc. (HSIC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Henry Schein and AWS drill down on AI-driven dentistry - Digital Commerce 360
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Tranche Update on Henry Schein, Inc.'s Equity Buyback Plan announced on December 13, 2018. - MarketScreener
HSIC: Partnership with AWS Elevates Stock Futures - StocksToTrade
Henry Schein Expands Strategic Partnership With KKR, Raises Annual Outlook - Benzinga
Henry Schein, Sanmina, Wingstop, Waters And Other Big Stocks Moving Higher On Tuesday - Benzinga
Does Henry Schein’s Upgraded 2025 Sales Outlook Signal More Sustainable Operational Gains for HSIC? - simplywall.st
Henry Schein, Inc. Raises Earnings Guidance for the Year 2025 - MarketScreener
Henry Schein lifts annual forecast on strong dental, medical equipment sales - Reuters
Henry Schein Partners with AWS to Transform Dental Practices - timothysykes.com
Henry Schein Q3 2025 slides: sales growth accelerates, EPS guidance raised - Investing.com
Henry Schein (HSIC) Surges 11% Following Strong Q3 Earnings Repo - GuruFocus
Henry Schein set for best day in 25 years on annual profit forecast raise - TradingView
Henry Schein Lifts Forecast As Dental Demand Drives Results - Finimize
Earnings call transcript: Henry Schein Q3 2025 beats forecasts, stock surges - Investing.com
William Blair Maintains Henry Schein(HSIC.US) With Hold Rating - 富途牛牛
Henry Schein rises after lifting 2025 guidance (HSIC:NASDAQ) - Seeking Alpha
Here's What Key Metrics Tell Us About Henry Schein (HSIC) Q3 Earnings - Yahoo Finance
Henry Schein (HSIC) Q3 Earnings and Revenues Beat Estimates - sharewise.com
Henry Schein’s Stock Gains Momentum Amid Strategic Moves - TipRanks
HSIC Stock Jumps on Q3 Earnings and Revenue Beat, '25 Outlook Up - TradingView
Henry Schein, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 27, 2025 - MarketScreener
Henry Schein One partners with AWS to develop AI dental solutions - Investing.com Australia
K.J. Harrison & Partners Inc Raises Stake in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein lifts annual forecast on strong dental, medical equipment sales By Reuters - Investing.com
Henry Schein Beats Estimates And Raises Its 2025 Outlook - Finimize
Henry Schein Inc (HSIC) Q3 2025 Earnings: Non-GAAP EPS of $1.38 Beats Estimate, Revenue Hits $3.3 Billion - GuruFocus
Henry Schein (HSIC) Exceeds Q3 Revenue Expectations Amid Strong Sales Performance - GuruFocus
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.19%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):